Cited by 614Treatment of Major DepressionBipolar Disorder and TreatmentClinical practice guidelines implementation

The DOI matches its Crossref record; 647 of the 648 references it cites were found in a registry or an index.

The 2020 Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders

Malhi, Gin S, Bell, Erica, Bassett, Darryl, Boyce, Philip, Bryant, Richard, Hazell, Philip, Hopwood, Malcolm, Lyndon, Bill, Mulder, Roger, Porter, Richard, Singh, Ajeet B, Murray, Greg·2021·Australian & New Zealand Journal of Psychiatry

DOI 10.1177/0004867420979353

Open this paper in CoChat — free account

Abstract

Objectives: To provide advice and guidance regarding the management of mood disorders, derived from scientific evidence and supplemented by expert clinical consensus to formulate s that maximise clinical utility. Methods: Articles and information sourced from search engines including PubMed, EMBASE, MEDLINE, PsycINFO and Google Scholar were supplemented by literature known to the mood disorders committee (e.g. books, book chapters and government reports) and from published depression and bipolar disorder guidelines. Relevant information was appraised and discussed in detail by members of the mood disorders committee, with a view to formulating and developing consensus-based recommendations and clinical guidance. The guidelines were subjected to rigorous consultation and external review involving: expert and clinical advisors, key stakeholders, professional bodies and specialist groups with interest in mood disorders. Results: The Royal Australian and New Zealand College of Psychiatrists mood disorders clinical practice guidelines 2020 (MDcpg 2020 ) provide up-to-date guidance regarding the management of mood disorders that is informed by evidence and clinical experience. The guideline is intended for clinical use by psychiatrists, psychologists, primary care physicians and others with an interest in mental health care. Conclusion: The MDcpg 2020 builds on the previous 2015 guidelines and maintains its joint focus on both depressive and bipolar disorders. It provides up-to-date recommendations and guidance within an evidence-based framework, supplemented by expert clinical consensus. Mood disorders committee: Gin S Malhi (Chair), Erica Bell, Darryl Bassett, Philip Boyce, Richard Bryant, Philip Hazell, Malcolm Hopwood, Bill Lyndon, Roger Mulder, Richard Porter, Ajeet B Singh and Greg Murray.

Integrity signals

Registry

Crossref · 10.1177/0004867420979353

Cites

647 of 647 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
Stress, appraisal, and coping
Eysenck, H. J. (1985) · Behaviour Research and Therapy · doi:10.1016/0005-7967(85)90087-7 · Cited by 32,038
Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption‐II
SAUNDERS, J. B., AASLAND, O. G., BABOR, T. F., DE LA FUENTE, J. R., & GRANT, M. (1993) · Addiction · doi:10.1111/j.1360-0443.1993.tb02093.x · Cited by 13,597 · cited 1×
“• Good quality patient psychoeducation can be found online (see 1 and 2, below) • Assessment should include measurement of current usage (e.g. AUDIT; Saunders et al., 1993), role of substances in risk profile (particularly risk for impulsivity, suicidality, foetal alcohol syndrome).”
Background
Diagnostic and Statistical Manual of Mental Disorders(DSM)
Leong, F. T. L. (2008) · Sage eBooks · doi:10.4135/9781412963978.n182 · Cited by 10,861
Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene
Caspi, A., Sugden, K., Moffitt, T. E., Taylor, A., Craig, I. W., Harrington, H., McClay, J., Mill, J., Martin, J., Braithwaite, A., et al. (2003) · Science · doi:10.1126/science.1083968 · Cited by 8,120
Untitled work
(1993) · Cited by 7,136
Emotion-regulation strategies across psychopathology: A meta-analytic review
Aldao, A., Nolen-Hoeksema, S., & Schweizer, S. (2010) · Clinical Psychology Review · doi:10.1016/j.cpr.2009.11.004 · Cited by 6,686 · cited 2×
“…factors include cognitive attributional style, personality traits (especially trait neuroticism), attachment styles, interpersonal relationships and coping behaviours (Liu and Alloy, 2010) (contemporary research in this domain is often framed in terms of emotion regulation (Aldao et al., 2010).”
Background
Cognitive-Behavioral Treatment of Borderline Personality Disorder
Cary, G. L. (1994) · American Journal of Psychotherapy · doi:10.1176/appi.psychotherapy.1994.48.1.155 · Cited by 6,299
Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643 · cited 2×
“A consensus statement (McClintock et al., 2018) contrasted the response and remission rates of rTMS for treatment-resistant depression with those of antidepressant treatment stages found in the STAR-D study (Rush et al., 2006) and suggested equivalent outcomes.”
Result
Rethinking rumination
Nolen-Hoeksema, S., Wisco, B. E., & Lyubomirsky, S. (2008) · Perspectives on Psychological Science · doi:10.1111/j.1745-6924.2008.00088.x · Cited by 5,172

Show all 648 references

Research works printed but not linked: 17

Abeywardana S, Sullivan EA (2008) Congenital anomalies in Australia 2002-2003. Birth Anomalies Series No. 3. Sydney, NSW, Australia: AIHW National Perinatal Statistics Unit.
Austin M-P, Highet N, Group EW (2017) Mental Health Care in the Perinatal Period: Australian Clinical Practice Guideline. Melbourne, VIC, Australia: Centre of Perinatal Excellence.
Baxter J (2008) Māori Mental Health Needs Profile: A Review of the Evidence: Summary. Palmerston North, New Zealand: Te Rau Matatini; Wellington, New Zealand: Ministry of Health.
Commonwealth of Australia (2013) A National Framework for Recovery-Oriented Mental Health Services: Policy and Theory. Canberra, ACT, Australia: Commonwealth of Australia.
Gill SP, Kellner CH (2019) Clinical practice recommendations for continuation and maintenance electroconvulsive therapy for depression: Outcomes from a review of the evidence and a consensus workshop held in Australia in May 2017. The Journal of ECT 35: 14–20.
10.1037/0021-843X.100.4.555 · DOI · Paper page
10.1037/0012-1649.35.5.1268 · DOI
Lewinsohn PM, Youngren MA, Grosscup SJ (1979) Reinforcement and Depression. New York: Academic Press.
National Institute for Health and Care Excellence (NICE) (2005) Depression in Children and Young People: Identification and Management in Primary, Community and Secondary Care. London: NICE.
NMHC (2014) The National Review of Mental Health Programmes and Services. Sydney, NSW, Australia: NMHC.
Paterson R, Durie M, Disley B, et al. (2018) He Ara Oranga: Report of the government inquiry into mental health and addiction. Government Inquiry into Mental Health and Addiction, Wellington, New Zealand, p. 219.
Productivity Commission (2019) Mental Health, Draft Report, Volume 1 (ed Commonwealth of Australia). Canberra, ACT, Australia: Productivity Commission.
10.1176/appi.books.9781615379422 · DOI
Te Rau Matatini (2015) Kaupapa Māori Mental Health and Addiction Services: Best Practice Framework. Wellington: Te Rau Matatini.
The British Psychological Society (2011) Good Practice Guidelines on the Use of Psychological Formulation. Leicester: The British Psychological Society.
10.1177/0269881107081550 · DOI · Paper page
US Department of Health and Human Services (2003) Achieving the Promise. Rockville, MD: New Freedom Commission on Mental Health.

Sorted by citations

Effectiveness of physical activity interventions for improving depression, anxiety and distress: an overview of systematic reviews
Singh, B., Olds, T., Curtis, R., Dumuid, D., Virgara, R., Watson, A., Szeto, K., O'Connor, E., Ferguson, T., Eglitis, E., et al. (2023) · British Journal of Sports Medicine · doi:10.1136/bjsports-2022-106195 · Cited by 1,049
“Four reviews 42 44 57 58 presented analyses by weekly session duration (68 component RCTs, >5016 participants, online supplemental eFigure 12).”
Background
Major depressive disorder
Marx, W., Penninx, B. W. J. H., Solmi, M., Furukawa, T. A., Firth, J., Carvalho, A. F., & Berk, M. (2023) · Nature Reviews Disease Primers · doi:10.1038/s41572-023-00454-1 · Cited by 910
“170 .”
Influential
Effect of exercise for depression: systematic review and network meta-analysis of randomised controlled trials
Noetel, M., Sanders, T., Gallardo-Gómez, D., Taylor, P., del Pozo Cruz, B., van den Hoek, D., Smith, J. J., Mahoney, J., Spathis, J., Moresi, M., et al. (2024) · BMJ · doi:10.1136/bmj-2023-075847 · Cited by 707
Exercise as medicine for depressive symptoms? A systematic review and meta-analysis with meta-regression
Heissel, A., Heinen, D., Brokmeier, L. L., Skarabis, N., Kangas, M., Vancampfort, D., Stubbs, B., Firth, J., Ward, P. B., Rosenbaum, S., et al. (2023) · British Journal of Sports Medicine · doi:10.1136/bjsports-2022-106282 · Cited by 449
Comorbidity between major depressive disorder and physical diseases: a comprehensive review of epidemiology, mechanisms and management
Berk, M., Köhler‐Forsberg, O., Turner, M., Penninx, B. W. J. H., Wrobel, A., Firth, J., Loughman, A., Reavley, N. J., McGrath, J. J., Momen, N. C., et al. (2023) · World Psychiatry · doi:10.1002/wps.21110 · Cited by 336
Virtual reality for supporting the treatment of depression and anxiety: scoping review
Baghaei, N., Chitale, V., Hlasnik, A., Stemmet, L., Liang, H.-N., & Porter, R. (2021) · JMIR Mental Health · doi:10.2196/29681 · Cited by 197
“It is supported by many guidelines as a first-line treatment for mood and anxiety disorders [6,7].”
BackgroundSelf-citation
Clinical guidelines for the use of lifestyle-based mental health care in major depressive disorder: World Federation of Societies for Biological Psychiatry (WFSBP) and Australasian Society of Lifestyle Medicine (ASLM) taskforce
Marx, W., Manger, S., Blencowe, M., Murray, G., Ho, F. Y., Lawn, S., Blumenthal, J. A., Schuch, F. B., Stubbs, B., Ruusunen, A. A., et al. (2022) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2022.2112074 · Cited by 200
“The extent to which the lifestyle therapies of diet, exercise, sleep and substance cessation are foundational refers to care that ‘needs to be undertaken to facilitate functional recovery’ as per its definition in RANZCP guidelines (Malhi et al. 2021).”
BackgroundInfluentialSelf-citation
The 2020 Royal Australian and New Zealand College of psychiatrists clinical practice guidelines for mood disorders: Bipolar disorder summary
Malhi, G. S., Bell, E., Boyce, P., Bassett, D., Berk, M., Bryant, R., Gitlin, M., Hamilton, A., Hazell, P., Hopwood, M., et al. (2020) · Bipolar Disorders · doi:10.1111/bdi.13036 · Cited by 152
“Therefore, to prevent both mania and depression, quetiapine can be combined with lithium (1) or valproate (2) and lithium can also be combined with aripiprazole (3) to prevent mania (*aripiprazole can also be administered as a long-acting depot) [Colour figure can be viewed at wileyonlinelibrary.”
BackgroundSelf-citation
Bipolar disorders: an update on critical aspects
Oliva, V., Fico, G., Prisco, M. D., Gonda, X., Rosa, A. R., & Vieta, E. (2024) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2024.101135 · Cited by 160
Neurobiological and behavioral mechanisms of circadian rhythm disruption in bipolar disorder: A critical multi‐disciplinary literature review and agenda for future research from the ISBD task force on chronobiology
McCarthy, M. J., Gottlieb, J. F., Gonzalez, R., McClung, C. A., Alloy, L. B., Cain, S., Dulcis, D., Etain, B., Frey, B. N., Garbazza, C., et al. (2022) · Bipolar Disorders · doi:10.1111/bdi.13165 · Cited by 136
“(1) Circadian function as causal explanation for emergence of disorder (specificity important, cause important); (2) Circadian function as biomarker (specificity and sensitivity important, cause irrelevant); (3) Circadian function as endophenotype (quantitative and dimensional, specificity not important, causality imp…”
Self-citation
The 2020 Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders: Major depression summary
Malhi, G. S., Bell, E., Singh, A., Bassett, D. L., Berk, M., Boyce, P. M., Bryant, R. A., Gitlin, M. J., Hamilton, A., Hazell, P., et al. (2020) · Bipolar Disorders · doi:10.1111/bdi.13035 · Cited by 121
“The first antidepressant (1) is then prescribed at the optimal dose and this can be increased (Increase Dose, ID) if necessary.”
BackgroundSelf-citation
Brain stimulation and other biological non-pharmacological interventions in mental disorders: An umbrella review
Rosson, S., de Filippis, R., Croatto, G., Collantoni, E., Pallottino, S., Guinart, D., Brunoni, A. R., Dell’Osso, B. M., Pigato, G., Hyde, J., et al. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104743 · Cited by 120
Exercise as a therapeutic modality for the prevention and treatment of depression
Blumenthal, J. A., & Rozanski, A. (2023) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2023.02.008 · Cited by 95
Major Depressive Disorder and Oxidative Stress: A Review of Peripheral and Genetic Biomarkers According to Clinical Characteristics and Disease Stages
Tayeb, A. E. K. A., Poinsignon, V., Chappell, K., Bouligand, J., Becquemont, L., & Verstuyft, C. (2023) · Antioxidants · doi:10.3390/antiox12040942 · Cited by 100
“Second, the underlying mechanisms of MDD are associated with various biological pathways intertwined with psychological and social factors [14].”
Background
Diagnosis and management of depression in adolescents
Korczak, D. J., Westwell-Roper, C. Y., & Sassi, R. B. (2023) · Canadian Medical Association Journal · doi:10.1503/cmaj.220966 · Cited by 97
Psychoeducation in bipolar disorder: A systematic review
Rabelo, J. L., Cruz, B. F., Ferreira, J. D. R., Viana, B. D. M., & Barbosa, I. G. (2021) · World Journal of Psychiatry · doi:10.5498/wjp.v11.i12.1407 · Cited by 76
The relationship between dose and serotonin transporter occupancy of antidepressants—a systematic review
Sørensen, A., Ruhé, H. G., & Munkholm, K. (2022) · Molecular Psychiatry · doi:10.1038/s41380-021-01285-w · Cited by 65
Clinical decision support for bipolar depression using large language models
Perlis, R. H., Goldberg, J. F., Ostacher, M. J., & Schneck, C. D. (2024) · Neuropsychopharmacology · doi:10.1038/s41386-024-01841-2 · Cited by 75
Understanding genetic risk factors for common side effects of antidepressant medications
Campos, A. I., Mulcahy, A., Thorp, J. G., Wray, N. R., Byrne, E. M., Lind, P. A., Medland, S. E., Martin, N. G., Hickie, I. B., & Rentería, M. E. (2021) · Communications Medicine · doi:10.1038/s43856-021-00046-8 · Cited by 63
Changes in antidepressant use in Australia: A nationwide analysis (2015–2021)
Costa, J. D. O., Gillies, M. B., Schaffer, A. L., Peiris, D., Zoëga, H., & Pearson, S. (2022) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/00048674221079740 · Cited by 61
Treatment-Resistant Bipolar Depression: Therapeutic Trends, Challenges and Future Directions
Elsayed, O. H., Ercis, M., Pahwa, M., & Singh, B. (2022) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s273503 · Cited by 70
Nutrition and bipolar disorder: a systematic review
Gabriel, F. C., Oliveira, M., Martella, B. D. M., Berk, M., Brietzke, E., Jacka, F. N., & Lafer, B. (2023) · Nutritional Neuroscience · doi:10.1080/1028415x.2022.2077031 · Cited by 59
“and dysfunctional eating behaviors are modifiable risk factors, it is possible that thesewill be converted into critical interventions for mental health [3,9,10].”
Background
Clinical Practice Guidelines for the Therapeutic Use of Repetitive Transcranial Magnetic Stimulation in Neuropsychiatric Disorders
Tikka, S. K., Siddiqui, M. A., Garg, S., Pattojoshi, A., & Gautam, M. (2023) · Indian Journal of Psychiatry · doi:10.4103/indianjpsychiatry.indianjpsychiatry_492_22 · Cited by 58
“…by an umbrella review of recent meta-analytic studies assessing the role of rTMS in various psychiatric disorders performed by the authors and supplemented by other clinical practice guidelines, [6] evidence-based guidelines, and umbrella reviews [7-9] , and consensus or expert recommendations.”
Systematic Umbrella Review and Meta-Meta-Analysis: Effectiveness of Physical Activity in Improving Depression and Anxiety in Children and Adolescents
Singh, B., Bennett, H., Miatke, A., Dumuid, D., Curtis, R., Ferguson, T., Brinsley, J., Szeto, K., Eglitis, E., Zhou, M., et al. (2025) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2025.04.007 · Cited by 70
Clinical practice guideline recommendations on tapering and discontinuing antidepressants for depression: a systematic review
Sørensen, A., Juhl Jørgensen, K., & Munkholm, K. (2022) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253211067656 · Cited by 52
Bipolar Disorder
Bauer, M. S. (2022) · Annals of Internal Medicine · doi:10.7326/aitc202207190 · Cited by 57
The biopsychosocial model – history, controversy and Engel
Lugg, W. (2021) · Australasian Psychiatry · doi:10.1177/10398562211037333 · Cited by 50
The Psychiatric Symptomology of Visual Snow Syndrome
Solly, E. J., Clough, M., Foletta, P., White, O. B., & Fielding, J. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.703006 · Cited by 50
“As with sleep dysfunction, a number of treatment avenues are available for anxiety and depression, both pharmacological and psychological (43, 44).”
Background
A systematic review of interventions in the early course of bipolar disorder I or II: a report of the International Society for Bipolar Disorders Taskforce on early intervention
Ratheesh, A., Hett, D., Ramain, J., Wong, E., Berk, L., Conus, P., Fristad, M. A., Goldstein, T. R., Hillegers, M. H. J., Jauhar, S., et al. (2023) · International Journal of Bipolar Disorders · doi:10.1186/s40345-022-00275-3 · Cited by 53
Self-citation
Clinical Effectiveness and Cost-Effectiveness of Supported Mindfulness-Based Cognitive Therapy Self-help Compared With Supported Cognitive Behavioral Therapy Self-help for Adults Experiencing Depression: The Low-Intensity Guided Help Through Mindfulness (LIGHTMind) Randomized Clinical Trial
Strauss, C., Bibby-Jones, A.-M., Jones, F., Byford, S., Heslin, M., Parry, G., Barkham, M., Lea, L., Crane, R., de Visser, R., et al. (2023) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2023.0222 · Cited by 45
“Mixed/multiple ethnic groups 9 (4) 11 (5)”
Background
Countering the declining use of lithium therapy: a call to arms
Malhi, G. S., Bell, E., Jadidi, M., Gitlin, M. J., & Bauer, M. (2023) · International Journal of Bipolar Disorders · doi:10.1186/s40345-023-00310-x · Cited by 44
Self-citation
Modulation of neuroimmune cytokine networks by antidepressants: implications in mood regulation
Nava, R. G., Adri, A. S., Filgueiras, I. S., Nóbile, A. L., Barcelos, P. M., Corrêa, Y. L. G., de Oliveira, S. F., Cabral‐Miranda, G., Dias, H. D., Schimke, L. F., et al. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03532-y · Cited by 53
“Lifestyle interventions (e.g., exercise, diet) could complement pharmacotherapy by reducing systemic in ﬂ ammation and improving HRQL, as seen in general MDD populations [184, 185].”
Psychobiotic effects on anxiety are modulated by lifestyle behaviors: a randomized placebo-controlled trial on healthy adults
Morales-Torres, R., Carrasco-Gubernatis, C., Grasso-Cladera, A., Cosmelli, D., Parada, F. J., & Palacios-García, I. (2023) · Nutrients · doi:10.3390/nu15071706 · Cited by 44
“From the clinical practice perspective, our results support the emphasis of recent psychiatry guidelines [93,94] and the nutritional and lifestyle psychiatry approach [64,86] to assess and prescribe lifestyle behaviors as a primary strategy, under both preventative and treatment approaches.”
Result
Ketamine and other glutamate receptor modulators for depression in adults with bipolar disorder
Dean, R. L., Marquardt, T., Hurducas, C., Spyridi, S., Barnes, A., Smith, R. P., Cowen, P. J., McShane, R. H., Hawton, K. E., Malhi, G. S., et al. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011611.pub3 · Cited by 43
Self-citation
Pharmacodynamic Interactions Between Ketamine and Psychiatric Medications Used in the Treatment of Depression: A Systematic Review
Veraart, J. K. E., Smith-Apeldoorn, S. Y., Bakker, I. M., Visser, B. A. E., Kamphuis, J., Schoevers, R. A., & Touw, D. J. (2021) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyab039 · Cited by 49
“However, to date, there are no clinical practice guidelines recommending the use of S-ketamine in depression (López-Díaz et al., 2019; Malhi et al., 2021).”
Background
Efficacy and safety of transcranial magnetic stimulation for treating major depressive disorder: An umbrella review and re-analysis of published meta-analyses of randomised controlled trials
Brini, S., Brudasca, N. I., Hodkinson, A., Kaluzinska, K., Wach, A., Storman, D., Prokop-Dorner, A., Jemioło, P., & Bala, M. M. (2023) · Clinical Psychology Review · doi:10.1016/j.cpr.2022.102236 · Cited by 44
Management of depression in patients with coronary artery disease: A systematic review
Akóṣílè, W., Tiyatiye, B., Colquhoun, D., & Young, R. M. (2023) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2023.103534 · Cited by 42
Delivery of Neuropsychological Interventions for Adult and Older Adult Clinical Populations: An Australian Expert Working Group Clinical Guidance Paper
Wong, D. K., Pike, K. E., Stolwyk, R. J., Allott, K., Ponsford, J. L., McKay, A., Longley, W. A., Bosboom, P. R., Hodge, M. A., Kinsella, G., et al. (2023) · Neuropsychology Review · doi:10.1007/s11065-023-09624-0 · Cited by 46
Association of polygenic score and the involvement of cholinergic and glutamatergic pathways with lithium treatment response in patients with bipolar disorder
Amare, A. T., Thalamuthu, A., Schubert, K. O., Fullerton, J. M., Ahmed, M. B., Hartmann, S., Papiol, S., Heilbronner, U., Degenhardt, F., Ayele, F. T., et al. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02149-1 · Cited by 42
“Since the discovery of lithium ’ s mood-stabilizing property in 1949 [5], it has been widely used as a ﬁ rst-line therapy for patients with BD [6, 7].”
Method
Co‐occurring depression and insomnia in Australian primary care: recent scientific evidence
Sweetman, A., Lack, L. C., Ryswyk, E. V., Vakulin, A., Reed, R. L., Battersby, M., Lovato, N., & Adams, R. (2021) · The Medical Journal of Australia · doi:10.5694/mja2.51200 · Cited by 39
Irritability in Mood Disorders: Neurobiological Underpinnings and Implications for Pharmacological Intervention
Bell, E., Boyce, P. M., Porter, R., Bryant, R. A., & Malhi, G. S. (2021) · CNS Drugs · doi:10.1007/s40263-021-00823-y · Cited by 37
“In mood disorders, and particularly bipolar disorder, mood stabilisers are frequently employed to ensure mood stability and reduce the likelihood of future episodes [106].”
BackgroundSelf-citation
Treatable Traits in Asthma: The Importance of Extrapulmonary Traits—GERD, CRSwNP, Atopic Dermatitis, and Depression/Anxiety
McDonald, V. M., Hamada, Y., Agustí, A. G. N., & Gibson, P. G. (2024) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2024.01.020 · Cited by 34
Bipolar II disorder: a state‐of‐the‐art review
Berk, M., Corrales, A., Trisno, R., Dodd, S., Yatham, L. N., Vieta, E., McIntyre, R. S., Suppes, T. M., & Agustini, B. (2025) · World Psychiatry · doi:10.1002/wps.21300 · Cited by 43
“Guidelines emphasize the importance of psychological interventions for the maintenance treatment of BD-II 244 .”
Holistic prevention and management of physical health side-effects of psychotropic medication: second report of the Lancet Psychiatry Physical Health Commission
Halstead, S., Yap, C. X., Warren, N., Agarwal, S. M., Brand, B. A., Chan, S. K. W., Cipriani, A., Correll, C. U., Crossley, N. A., D’Ambrosio, E., et al. (2025) · The Lancet Psychiatry · doi:10.1016/s2215-0366(25)00162-2 · Cited by 39
Differences in the prophylactic effect of serum lithium levels on depression and mania in bipolar disorder: A dose-response meta-analysis
Hsu, C., Tsai, S., Tseng, P., Liang, C., Vieta, E., Carvalho, A. F., Stubbs, B., Kao, H.-Y., Tu, Y., & Lin, P. (2022) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2022.01.112 · Cited by 34
Lifestyle medicine for anxiety symptoms: A meta-analysis of randomized controlled trials
Wong, V. W.-H., Ho, F. Y., Shi, N.-K., Sarris, J. J., Ng, C. H., & Tam, O. K.-Y. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.04.151 · Cited by 32
Head-To-Head Comparison of Vortioxetine Versus Desvenlafaxine in Patients With Major Depressive Disorder With Partial Response to SSRI Therapy
McIntyre, R. S., Florea, I., Pedersen, M. M., & Christensen, M. C. (2023) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.23m14780 · Cited by 34
Optimal exercise modality and dose to improve depressive symptoms in adults with major depressive disorder: A systematic review and Bayesian model-based network meta-analysis of RCTs
Tian, S., Liang, Z., Qui, F., Yu, Y., Wang, C., Zhang, M., & Wang, X. (2024) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2024.06.031 · Cited by 35
Abnormal habenula functional connectivity characterizes treatment-resistant depression
Barreiros, A. R., Breukelaar, I. A., Mayur, P. M., Andepalli, J., Tomimatsu, Y., Funayama, K., Foster, S., Boyce, P. M., Malhi, G. S., Harris, A. W. F., et al. (2022) · NeuroImage Clinical · doi:10.1016/j.nicl.2022.102990 · Cited by 33
“This definition has also recently been reframed to include patients who fail to respond to neuromodulation and psychotherapies (Malhi et al., 2019).”
BackgroundSelf-citation
Novel ultrasound neuromodulation therapy with transcranial pulse stimulation (TPS) in Parkinson’s disease: a first retrospective analysis
Osou, S., Radjenovic, S., Bender, L., Gaal, M., Zettl, A., Dörl, G., Matt, E., & Beisteiner, R. (2023) · Journal of Neurology · doi:10.1007/s00415-023-12114-1 · Cited by 36
Pramipexole Augmentation for Treatment-Resistant Unipolar and Bipolar Depression in the Real World: A Systematic Review and Meta-Analysis
Tundo, A., Betrò, S., de Filippis, R., Marchetti, F., Nacca, D., Necci, R., & Iommi, M. (2023) · Life · doi:10.3390/life13041043 · Cited by 31
“ADs are employed in monotherapy for unipolar depression [3,9,10] and combined with mood stabilizers or second-generation antipsychotics for bipolar depression without mixed features, rapid-cycling course, and treatment-emergent manic/hypomanic switch [3,6,11,12].”
Background
Efficacy of Repetitive Transcranial Magnetic Stimulation (rTMS) Combined with Psychological Interventions: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Xu, X., Xu, M., Su, Y., Cao, T. V., Nikolin, S., Moffa, A. H., Loo, C. K. A., & Martin, D. M. (2023) · Brain Sciences · doi:10.3390/brainsci13121665 · Cited by 31
The Effect of Interventions That Target Multiple Modifiable Health Behaviors on Symptoms of Anxiety and Depression in Young People: A Meta-Analysis of Randomized Controlled Trials
Bourke, M., Patten, R. K., Dash, S. R., Pascoe, M. C., Craike, M. J., Firth, J., Bailey, A. P., Jacka, F. N., & Parker, A. G. (2021) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2021.08.005 · Cited by 33
Adjunctive lumateperone ( ITI ‐007) in the treatment of bipolar depression: Results from a randomized placebo‐controlled clinical trial
Suppes, T. M., Durgam, S., Kozauer, S. G., Chen, R., Lakkis, H. D., Davis, R. E., Satlin, A., Vanover, K. E., Mates, S. L., McIntyre, R. S., et al. (2023) · Bipolar Disorders · doi:10.1111/bdi.13310 · Cited by 32
Important adverse events to be evaluated in antidepressant trials and meta-analyses in depression: a large international preference study including patients and healthcare professionals
Chevance, A., Tomlinson, A., Ravaud, P., Touboul, S., Henshall, C. L., Tran, V.-T., & Cipriani, A. (2022) · Evidence-Based Mental Health · doi:10.1136/ebmental-2021-300418 · Cited by 28
Antidepressant discontinuation syndrome: A state-of-the-art clinical review
Fornaro, M., Cattaneo, C. I., Berardis, D. D., Ressico, F. V., Martinotti, G., & Vieta, E. (2022) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2022.10.005 · Cited by 31
Lithium concentration and recurrence risk during maintenance treatment of bipolar disorder: Multicenter cohort and meta‐analysis
Hsu, C., Carvalho, A. F., Tsai, S., Wang, L., Tseng, P., Lin, P., Tu, Y., Vieta, E., Solmi, M., Hung, C., et al. (2021) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13346 · Cited by 27
“Due to the different ranges of lithium serum levels in the included studies, we used the following criteria to define the value of serum levels in the comparison group: (1) the mean or median of each serum level category; (2) when the ranges of each serum level category were reported, the average value of the lower an…”
BackgroundMethod
The acceptability of lifestyle medicine for the treatment of mental illness: perspectives of people with and without lived experience of mental illness
Richardson, K. E., Petukhova, R., Hughes, S. D., Pitt, J., Yücel, M., & Segrave, R. A. (2024) · BMC Public Health · doi:10.1186/s12889-024-17683-y · Cited by 29
“Physical exercise, sleep, diet, mindfulness meditation, and strengthening positive relationships are examples of lifestyle medicine activities with demonstrated efficacy to prevent and treat a wide variety of mental illnesses; albeit to varying degrees [7, 9, 12, 13].”
BackgroundInfluential
Evaluating virtual reality technology in psychotherapy: impacts on anxiety, depression, and ADHD
Wang, P., Ai, X., Zhang, X. Q., Ma, F., Zhuang, Y., & Wang, S. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1480788 · Cited by 33
Efficacy of cannabinoids in neurodevelopmental and neuropsychiatric disorders among children and adolescents: a systematic review
Rice, L. J., Cannon, L., Dadlani, N., Cheung, M. M. Y., Einfeld, S., Efron, D., Dossetor, D. R., & Elliott, E. J. (2023) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-023-02169-w · Cited by 33
“Clinical practice guidelines for the assessment and treat-ment of mood disorders note that the evidence for efficacy of CBD in depression remains unproven [62].”
Background
Prevalence of cognitive impairments and strengths in the early course of psychosis and depression
Stainton, A., Chisholm, K., Griffiths, S. L., Kambeitz‐Ilankovic, L., Wenzel, J., Bonivento, C., Brambilla, P., Iqbal, M., Lichtenstein, T., Rosen, M., et al. (2023) · Psychological Medicine · doi:10.1017/s0033291723001770 · Cited by 27
Differentiating mindfulness-integrated cognitive behavior therapy and mindfulness-based cognitive therapy clinically: the why, how, and what of evidence-based practice
Francis, S. E. B., Shawyer, F., Cayoun, B. A., Grabovac, A. D., & Meadows, G. N. (2024) · Frontiers in Psychology · doi:10.3389/fpsyg.2024.1342592 · Cited by 31
Promoting physical activity for mental health: an updated evidence review and practical guide
McKeon, G., Curtis, J., & Rosenbaum, S. (2022) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000796 · Cited by 29
“This evidence is reflected in international treatment guidelines for mood disorders [31].”
Background
Experience of antidepressant use and discontinuation: A qualitative synthesis of the evidence
Crowe, M., Inder, M., & McCall, C. (2022) · Journal of Psychiatric and Mental Health Nursing · doi:10.1111/jpm.12850 · Cited by 28
“Despite the high rates of prescribing the evidence of the efficacy of antidepressants is tenuous even though clinical guidelines (Kennedy et al., 2016; Malhi et al., 2021; National Institute for Health and Care Excellence, 2018) recommend their use for moderate to severe depression.”
Background
Childhood trauma and depressive symptoms in bipolar disorder: A network analysis
Wrobel, A. L., Cotton, S., Jayasinghe, A., Diaz‐Byrd, C., Yocum, A. K., Turner, A., Dean, O. M., Russell, S. E., Duval, E. R., Ehrlich, T. J., et al. (2023) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13528 · Cited by 25
The efficacy of exercise interventions on depressive symptoms and cognitive function in adults with depression: An umbrella review
Liu, Y., Zhao, G., Guo, J., Qu, H., Kong, L., & Yue, W. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.09.074 · Cited by 29
Vilazodone for Major Depression in Adults: Pharmacological Profile and an Updated Review for Clinical Practice
Chauhan, M., Parry, R., & Bobo, W. V. (2022) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s279342 · Cited by 25
Specific metabolic syndrome components predict cognition and social functioning in people with type 2 diabetes mellitus and severe mental disorders
Sánchez‐Ortí, J. V., Balanzá‐Martínez, V., Correa‐Ghisays, P., Selva‐Vera, G., Vila‐Francés, J., Magdalena‐Benedito, R., Valenzuela, C. S. M., Víctor, V. M., Escribano‐López, I., Hernández‐Mijares, A., et al. (2022) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13433 · Cited by 24
Psychiatry and/or recovery: a critical analysis
Crowe, M. (2022) · International Journal of Mental Health Nursing · doi:10.1111/inm.13072 · Cited by 26
“The guidelines are highly cited as evidence to support further published opinion and research, and the previous guidelines (Malhi et al. 2021) garnered 742 citations times (Google Scholar August 2022).”
Background
Under the umbrella of depression and Alzheimer’s disease physiopathology: Can cannabinoids be a dual-pleiotropic therapy?
Fonseca, C., Ettcheto, M., Bicker, J., Fernandes, M. J., Falcão, A. C., Camins, A., & Fortuna, A. C. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101998 · Cited by 31
What not to use in bipolar disorders: A systematic review of non-recommended treatments in clinical practice guidelines
Gomes, F. A., Cerqueira, R. O., Lee, Y. L., Mansur, R. B., Kapczinski, F. P., McIntyre, R. S., Yatham, L. N., Berk, M., Milev, R. V., & Brietzke, E. M. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.11.007 · Cited by 23
When and How to Use Lithium Augmentation for Treating Major Depressive Disorder
Ercis, M., Özerdem, A., & Singh, B. (2023) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.23ac14813 · Cited by 23
Efficacy of lifestyle medicine on sleep quality: A meta-analysis of randomized controlled trials
Wong, V. W.-H., Ho, F. Y., Wong, Y. S.-H., Chung, K., Yeung, W., Ng, C. H., & Sarris, J. J. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.02.111 · Cited by 22
Mixed Depression: A Mini-Review to Guide Clinical Practice and Future Research Developments
Natale, A., Mineo, L., Fusar‐Poli, L., Aguglia, A., Rodolico, A., Tusconi, M., Amerio, A., Serafini, G., Amore, M., & Aguglia, E. (2022) · Brain Sciences · doi:10.3390/brainsci12010092 · Cited by 26
“Moreover, treatment recommendations for episodes with mixed features are available in the updated editions of some international guidelines for BD: Evidence-based guidelines for treating bipolar disorder: revised third edition recommendations from the British Association for Psychopharmacology (2016; [74]); the Intern…”
BackgroundMethod
Social Rhythm Disruption is Associated with Greater Depressive Symptoms in People with Mood Disorders: Findings from a Multinational Online Survey During COVID-19
Kahawage, P., Bullock, B., Meyer, D., Gottlieb, J. F., Crowe, M., Swartz, H. A., Yatham, L. N., Inder, M., Porter, R., Nierenberg, A. A., et al. (2022) · The Canadian Journal of Psychiatry · doi:10.1177/07067437221097905 · Cited by 25
Self-citation
Description of antidepressant withdrawal symptoms in clinical practice guidelines on depression: A systematic review
Sørensen, A., Jørgensen, K. J., & Munkholm, K. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.08.011 · Cited by 23
Summary of the 2023 international evidence‐based guideline for the assessment and management of polycystic ovary syndrome: an Australian perspective
Teede, H. J., Mousa, A., Tay, C. T., Costello, M., Brennan, L., Norman, R. J., Peña, A. S., Boyle, J. A., Joham, A. E., Berry, L., et al. (2024) · The Medical Journal of Australia · doi:10.5694/mja2.52432 · Cited by 26
Psychotropic medication use in people living with severe and persistent mental illness in the Australian community: a cross-sectional study
Hu, J., McMillan, S. S., Theodoros, T., Collins, J. C., El‐Den, S., O’Reilly, C. L., & Wheeler, A. (2022) · BMC Psychiatry · doi:10.1186/s12888-022-04324-0 · Cited by 21
“Co-prescription of lithium and lamotrigine, as the use of alternate moodstabiliser polypharmacy, is also supported by clinical practice guidelines for bipolar affective disorders [26].”
Background
Psychodynamic Psychotherapy for Postpartum Depression: A Systematic Review
Valverde, N., Mollejo, E., Legarra, L., & Gómez, M. L. N. (2023) · Maternal and Child Health Journal · doi:10.1007/s10995-023-03655-y · Cited by 21
Utility of pharmacogenetic testing to optimise antidepressant pharmacotherapy in youth: a narrative literature review
Roberts, B., Cooper, Z., Lu, S. Y., Stanley, S. H., Majda, B. T., Collins, K. R. L., Gilkes, L., Rodger, J., Akkari, P. A., & Hood, S. D. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1267294 · Cited by 22
“Minor metabolic pathways in parentheses (Cacabelos, 2012; Samer et al., 2013; Malhi et al., 2015; Malhi et al., 2021; Zemanova et al., 2022).”
Background
Beneficial and harmful effects of tricyclic antidepressants for adults with major depressive disorder: a systematic review with meta-analysis and trial sequential analysis
Kamp, C. B., Petersen, J. J., Faltermeier, P., Juul, S., Siddiqui, F., Barbateskovic, M., Kristensen, A. T., Moncrieff, J., Horowitz, M. A., Hengartner, M. P., et al. (2024) · BMJ Mental Health · doi:10.1136/bmjment-2023-300730 · Cited by 23
“13 14 The WHO Model List of Essential Medicines also includes the tricyclic antidepressant amitriptyline as one of just two essential antidepressants for the treatment of depressive disorders.”
French Society for Biological Psychiatry and Neuropsychopharmacology (AFPBN) guidelines for the management of patients with partially responsive depression and treatment-resistant depression: Update 2024
Yrondi, A., Javelot, H., Nobile, B., Boudieu, L., Aouizerate, B., Llorca, P., Charpeaud, T., Bennabi, D., Antoine Lefrere, A., & Samalin, L. (2024) · L Encéphale · doi:10.1016/j.encep.2023.11.029 · Cited by 22
Training needs and curriculum of continuing medical education among general practitioners in Tibet, China: A cross-sectional survey
An, K., Zhang, L., Qiao, R., Li, C., Zhong, Q., Ma, Y., Rao, X., Mao, T., Liu, F., Zhuo, Q., et al. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.914847 · Cited by 20
Korean Medication Algorithm Project for Bipolar Disorder 2022: Comparisons with Other Treatment Guidelines
Jeong, J., Bahk, W., Woo, Y. S., Yoon, B.-H., Lee, J. G., Kim, W., Sohn, I., Park, S., Shim, S.-H., Seo, J. S., et al. (2023) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2023.21.1.32 · Cited by 20
“views of current recommendations for diagnosis and management [24].”
Influential
Electroconvulsive therapy for treatment-resistant depression
Hsieh, M. H. (2023) · Progress in brain research · doi:10.1016/bs.pbr.2023.01.004 · Cited by 26
How to save a life: From neurobiological underpinnings to psychopharmacotherapies in the prevention of suicide
Gonda, X., Döme, P., Serafini, G., & Pompili, M. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108390 · Cited by 21
Moving from serotonin to serotonin-norepinephrine enhancement with increasing venlafaxine dose: clinical implications and strategies for a successful outcome in major depressive disorder
Fagiolini, A. M., Cardoner, N., Pırıldar, Ş., Ittsakul, P., Ng, B., Duailibi, K., & Hindy, N. E. (2023) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2023.2242264 · Cited by 21
“The 2020 clinical practice guidelines for mood disorders by The Royal Australian and New Zealand College of Psychiatrists [45] and the 2016 clinical guidelines for MDD from the Canadian Network for Mood and Axiety Treatments (CANMAT) [44] provide examples of a cluster-based approach, outlining a…”
Comparability of Patients in Trials of eHealth and Face-to-Face Psychotherapeutic Interventions for Depression: Meta-synthesis
Aemissegger, V., López‐Alcalde, J., Witt, C. M., & Barth, J. (2022) · Journal of Medical Internet Research · doi:10.2196/36978 · Cited by 20
“Our searches identified a high number of RCTs, which confirms the recent expansion of research into digital interventions [6,43].”
BackgroundInfluential
The influence of childhood trauma on the treatment outcomes of pharmacological and/or psychological interventions for adolescents and adults with bipolar disorder: A systematic review and meta-analysis
Wrobel, A. L., Jayasinghe, A., Russell, S. E., Marx, W., Alameda, L., Dean, O. M., Cotton, S., Berk, M., & Turner, A. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.09.103 · Cited by 19
Behavioral Emotion Regulation Strategies and Symptoms of Psychological Distress Among Turkish University Students
Keskiner, E. Ş., Şahin, E., Topkaya, N., & Yiğit, Z. (2024) · Behavioral Science · doi:10.3390/bs15010006 · Cited by 18
“Moreover, research indicates that anxiety and stress are often situational and related to immediate or future threats, whereas depression is more frequently past-oriented and linked to a sense of loss or failure (Beck et al., 2024; Lopes & Nihei, 2021; Malhi et al., 2021).”
Effect of exercise interventions on depression, anxiety, and self-esteem in children and adolescents: a systematic review and network meta-analysis
Zhou, S., Xu, Y., Yang, Y., Song, H., Wang, X., & Yu, Y. (2025) · BMC Public Health · doi:10.1186/s12889-025-25044-6 · Cited by 22
Diet and depression: future needs to unlock the potential
Marx, W., Lane, M. M., Hockey, M., Aslam, H., Walder, K. R., Borsini, A., Firth, J., Pariante, C. M., Berding, K., Cryan, J. F., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01360-2 · Cited by 18
Korean Medication Algorithm Project for Bipolar Disorder 2022, Fifth Revision: An Executive Summary
Woo, Y. S., Bahk, W., Jeong, J., Lee, J. G., Kim, W., Sohn, I., Park, S., Shim, S.-H., Seo, J. S., Choo, I. H., et al. (2022) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2022.20.4.747 · Cited by 17
“asidone, asenapine, and cariprazine that have been recommended in foreign clinical practice guidelines [5,7,36] because they are not available in South Korea.”
Background
Impact of the early phase of the COVID-19 pandemic on the use of mental health services in South Korea: a nationwide, health insurance data-based study
Joo, S. W., Kim, H., Jo, Y. T., Ahn, S., Choi, Y. J., Choi, W., & Lee, J. S. (2022) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-022-02382-z · Cited by 17
Association between the mood stabilizing treatment of bipolar disorder and risk of suicide attempts: A self-controlled case series study
Ng, V. W. S., Leung, M. T. Y., Chan, E. W., Lee, E. H. M., Hayes, J., Osborn, D., Wing, Y. K., Lau, W. C. Y., Man, K. K. C., & Wong, I. C. K. (2023) · Psychiatry Research · doi:10.1016/j.psychres.2023.115236 · Cited by 18
“Lithium is recommended as a first-line treatment of BPD by international clinical guidelines because of its profound efficacy in relieving mood fluctuation and relapse prevention (Malhi et al., 2021; NICE, 2014; Yatham et al., 2018).”
Background
Environmental Engineering 3.0: Faced with Planetary Problems, Solutions Must Scale-Up Caring
Oerther, D. B., Oerther, S. E., & McCauley, L. (2024) · Journal of Environmental Engineering · doi:10.1061/joeedu.eeeng-7764 · Cited by 16
Practice Guidelines for Bipolar Disorder by the JSMD (Japanese Society of Mood Disorders)
Kato, T., Ogasawara, K., Motomura, K., Kato, M., Tanaka, T., Takaesu, Y., Nio, S., Kishi, T., So, M., Nemoto, K., et al. (2024) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.13724 · Cited by 18
Early use of long‐acting injectable antipsychotics in bipolar disorder type I: An expert consensus
Vieta, E., Tohen, M. F., McIntosh, D., Kessing, L. V., Sajatovic, M., & McIntyre, R. S. (2024) · Bipolar Disorders · doi:10.1111/bdi.13498 · Cited by 16
“62 It is important to note that international guidelines may be made obsolete early on if the latest findings are available soon after publication.”
Depression
Malhi, G. S., Bell, E., Stavdal, A., Wu, C., Naylor, A., & Kumari, V. (2026) · The Lancet · doi:10.1016/s0140-6736(26)00201-1 · Cited by 17
Self-citation
The Korean Medication Algorithm Project for Depressive Disorder 2021: Comparisons with Other Treatment Guidelines
Woo, Y. S., Bahk, W., Seo, J. S., Park, Y., Kim, W., Jeong, J., Shim, S.-H., Lee, J. G., Jang, S.-H., Yang, C.-M., et al. (2022) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2022.20.1.37 · Cited by 15
“recommend AD monotherapy for moderate-to-severe depressive episodes without psychotic features [12,14,16,17], and augmentation with AAP is recommended for psychotic depression (Table 2).”
Background

Authors: Malhi, G. S., Bell, E., Bassett, D., Boyce, P., Bryant, R., Hazell, P., Hopwood, M., Lyndon, B., Mulder, R., Porter, R., Singh, A. B., & Murray, G.
Affiliations: The University of Sydney (AU)
Consultant Psychiatrist, Perth, WA, Australia
UNSW Sydney (AU)
The University of Melbourne (AU)
University of Otago (NZ)
Deakin University (AU)
Swinburne University of Technology (AU)
Corresponding author: Malhi, Gin S
ORCID: Malhi, Gin S
Bell, Erica
Boyce, Philip
Bryant, Richard
Hazell, Philip
Hopwood, Malcolm
Mulder, Roger
Porter, Richard
Singh, Ajeet B
Murray, Greg
Venue: Australian & New Zealand Journal of Psychiatry
Publisher: SAGE Publications
Published: 2020-12-22
Volume: 55
Issue: 1
Pages: 7-117
ISSN: 0004-8674 (ISSN-L)
1440-1614
DOI: 10.1177/0004867420979353
OpenAlex: W3145708260
Semantic Scholar: aebe450498c0d007898716e02f680b40b9ae3f78
Cited by: 614
References: 648
Citations by year: 2026: 115 · 2025: 131 · 2024: 101 · 2023: 117 · 2022: 82 · 2021: 65 · 2020: 3
FWCI: 40.01
Type: journal article
Language: en
Open access: closed
Licence: journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations: Australian & New Zealand Journal of Psychiatry (publishedVersion)
PubMed (publishedVersion)
Swinburne figshare (Swinburne University of Technology) (submittedVersion)
Funders: RANZCP
Topics: Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Clinical practice guidelines implementation
Keywords: mood disorders, depression, bipolar disorder, depression treatment, bipolar disorder management
MeSH terms: Australia, Humans, New Zealand, Psychiatry, Societies, Medical, Practice Guidelines as Topic, Mood Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The 2020 Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks